CSI Market
Sign In | Register

Alterola Biotech Inc (ALTA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ALTA quarterly Cash Flow →
From Alterola Biotech Inc through Sep 30 2020, changes in Mar 31 2024's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2024)
12 Months 		(Mar 31 2023) (Mar 31 2022) (Mar 31 2021) (Sep 30 2020)
Operating Activities
Income-2.37
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Payments for Origination and Purchases of Loans Held-for-sale0.00
Mineral Property Option Costs-
Impairment-
Foreign Exchange Adjustment On Promissory Note-
Increase Decrease In V A T Taxes Receivable0.07
Stock Issued During Period Issued For Services-
Stock Issued During Period Value Issued For Services Directors-
Shares Issued For Warrants During Period-
Income taxes0.00
Gain (Loss) on Sales of Loans, Net0.00
Increase (Decrease) in Accounts Receivable0.00
Accounts Payable1.69
Increase (Decrease) in Accrued Liabilities0.10
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.93
Discontinued operations0.00
Net Cash flow from Operating Activities-1.45
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities0.00
Payments to Acquire Available-for-sale Securities, Debt0.00
Proceeds from Sale of Other Real Estate0.00
Website Development-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans and Leases0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Increase (Decrease) in Lease Acquisition Costs0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.54
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits0.00
Other financing activities net0.00
Other net0.95
Advance From Director-
Cash And Equivalents Beginning-
Stock Issued During Period Value Issued For Services-
Stock Issued During Period Value Acquisitions-
Proceeds From Issuance Of Common Stock For Services-
Proceeds From Issuance Of Common Stock For C2 Acquisition-
Shares Issued For Cash Financing-
Shares Issued For Stock Subscription-
Acquisition Of Treasury Shares-
Treasury Stock Value Acquired Cost Method-
Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments-
Foreign Currency Transaction Gain Loss Excluding Investment Price Change After Tax-0.03
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.01
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.47
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-1.45
Total Cash Flow0.02
4 historic quarters locked

Sign in to unlock the full Alterola Biotech Inc cash flow history.

Sign In Create Free Account

About Alterola Biotech Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001663577-24-000211

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License